Alps Advisors Inc. Sells 28,550 Shares of Procter & Gamble Company (The) $PG

Alps Advisors Inc. cut its stake in Procter & Gamble Company (The) (NYSE:PG) by 22.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 100,397 shares of the company’s stock after selling 28,550 shares during the period. Alps Advisors Inc.’s holdings in Procter & Gamble were worth $15,426,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Corundum Trust Company INC bought a new position in Procter & Gamble in the third quarter valued at $32,000. Mid American Wealth Advisory Group Inc. acquired a new stake in Procter & Gamble in the 2nd quarter valued at $34,000. Marquette Asset Management LLC bought a new stake in Procter & Gamble during the 3rd quarter worth about $37,000. Finally, Manning & Napier Advisors LLC acquired a new position in shares of Procter & Gamble during the 3rd quarter worth about $44,000. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Marc S. Pritchard sold 95,903 shares of the business’s stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the completion of the sale, the insider directly owned 182,607 shares in the company, valued at $27,601,048.05. The trade was a 34.43% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 8,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $158.00, for a total value of $1,264,000.00. Following the completion of the transaction, the chief executive officer directly owned 6,571 shares in the company, valued at approximately $1,038,218. This represents a 54.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. BNP Paribas Exane lowered their target price on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a research report on Friday, January 16th. Piper Sandler began coverage on Procter & Gamble in a research report on Wednesday, January 7th. They set a “neutral” rating and a $150.00 price target on the stock. Dbs Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research note on Monday, October 27th. Finally, UBS Group upped their price target on shares of Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Thirteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $167.67.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Market technicals and dividend profile: PG has shown a strong technical bounce (breaking above its 200‑day SMA) and benefits from a steady dividend track record, which is attracting risk‑off flows into staples. 3 Consumer Staples Stocks Breaking Out This Month
• Positive Sentiment: Brand/innovation catalysts: Analysts note P&G is pushing faster Beauty & Personal Care innovation and premiumization to support pricing power and mix improvement—potentially underpinning revenue and margin resilience. Can Beauty & Personal Care Innovation Drive Procter & Gamble’s Growth?
• Positive Sentiment: High‑profile marketing push: A Super Bowl / Old Spice immersive experience is a short‑term promotional catalyst that can lift grooming revenues and brand engagement. Old Spice Super Bowl Experience
• Positive Sentiment: Subsidiary performance and shareholder returns: Procter & Gamble Health (India) reported strong Q3 FY26 results and declared an interim + special payout, underscoring cash generation in some business units. Procter & Gamble Health Posts Strong Q3 FY26 Results
• Neutral Sentiment: Wall Street positioning: The consensus broker view is a “Moderate Buy” with a ~$167 target—supportive context but not a new catalyst. PG Receives Consensus Recommendation of “Moderate Buy”
• Neutral Sentiment: Valuation/earnings context: Recent commentary reviews PG’s mixed Q2 results, strong brand campaigns and valuation—useful framing for investors but unlikely to move the stock alone. A Look At Procter & Gamble (PG) Valuation
• Negative Sentiment: Analyst estimate cuts: Zacks Research trimmed multiple quarterly and FY EPS forecasts (FY2027/FY2028 and selected quarters), which could pressure forward expectations and act as a near‑term headwind. Here is What to Know Beyond Why Procter & Gamble is a Trending Stock
• Negative Sentiment: Insider selling: CEO Ma. Fatima Francisco sold ~8,000 shares (~$1.26M) and materially reduced her direct holding; while insiders sell for many reasons, some investors view such disclosures negatively. SEC Form 4 – Insider Sale
• Negative Sentiment: Sector valuation risk: Coverage (e.g., Barron’s) warns consumer staples are “frothy” after the recent run; elevated valuations across defensive names could prompt profit‑taking that weighs on PG. Staples Stocks Are Known for Safety. Now They Look Way Too Frothy.

Procter & Gamble Trading Up 0.5%

Shares of Procter & Gamble stock opened at $159.33 on Monday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. The business has a fifty day simple moving average of $145.75 and a two-hundred day simple moving average of $150.30. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $179.99. The company has a market capitalization of $370.28 billion, a price-to-earnings ratio of 23.60, a P/E/G ratio of 5.29 and a beta of 0.38.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.02. The company had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, January 23rd. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is 62.67%.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.